Lista de obras - Kenny Roose - Dominio Público Uruguay

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

artículo científico publicado en 2015

A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection

artículo científico publicado en 2012

A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection

artículo científico publicado en 2016

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

artículo científico publicado en 2008

Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza

artículo científico publicado en 2017

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

artículo científico publicado el 21 de octubre de 2010

Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide

artículo científico publicado en 2017

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection

artículo científico publicado en 2017

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

artículo científico publicado en 2017

Correction: A20 () Deficiency in Myeloid Cells Protects against Influenza A Virus Infection

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

artículo científico publicado en 2017

How mRNA therapeutics are entering the monoclonal antibody field

artículo científico publicado en 2019

Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12.

artículo científico publicado en 2017

M2e-based universal influenza A vaccine

artículo científico publicado en 2009

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

artículo científico publicado en 2013

Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection

scientific article published on 17 July 2019

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus

artículo científico publicado en 2017

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages

artículo científico publicado en 2015

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

artículo científico publicado en 2014

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

artículo científico publicado en 2013

Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization

article

Reverse engineering synthetic antiviral amyloids

artículo científico publicado en 2020

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

artículo científico publicado en 2020

Sequence-dependent internalization of aggregating peptides

artículo científico publicado en 2014

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

artículo científico publicado en 2014

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

artículo científico publicado en 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

artículo científico publicado en 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

artículo científico publicado en 2020

Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody

artículo científico publicado en 2015

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration

artículo científico publicado en 2020

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

artículo científico publicado en 2018

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses

artículo científico publicado en 2016

Lista de obras de Kenny Roose

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection

A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Correction: A20 () Deficiency in Myeloid Cells Protects against Influenza A Virus Infection

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

How mRNA therapeutics are entering the monoclonal antibody field

Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12.

M2e-based universal influenza A vaccine

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization

Reverse engineering synthetic antiviral amyloids

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Sequence-dependent internalization of aggregating peptides

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses